Efficacy of current growth hormone treatments and future therapies.
Despite huge advances having been made in some areas of medicine, options for the treatment of GH deficiency (GHD) have remained constant since the introduction of GH in the 1950s. Several initiatives have been introduced to improve the understanding and treatment of GHD with GH, including the long-term Hypopituitary Control and Complications Study (HypoCCS) and the issuance of clinical guidelines. This article considers the impact of these initiatives and considers new treatment options which will potentially provide important future benefits for GHD patients.
Ross
R
R
School of Medicine and Biomedical Sciences, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK. r.j.ross@sheffield.ac.uk
D005544:Forecasting; D006130:Growth Disorders / Q000188:drug therapy*; D020249:Hormone Replacement Therapy / Q000639:trends*; D019382:Human Growth Hormone / Q000172:deficiency / Q000627:therapeutic use*; D006801:Humans; D007018:Hypopituitarism / Q000150:complications / Q000517:prevention & control; D007558:Italy; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
D019382:Human Growth Hormone